← Back to Research Radar
Academic Publication Academic Publication

Structure-based drug design with equivariant diffusion models

164
Citations
December 9, 2024
Published Date

Research Abstract & Technology Focus

AbstractStructure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods leverage structural data of drugs with their protein targets to propose new drug candidates. However, most existing methods focus exclusively on bottom-up de novo design of compounds or tackle other drug development challenges with task-specific models. The latter requires curation of suitable datasets, careful engineering of the models and retraining from scratch for each task. Here we show how a single pretrained diffusion model can be applied to a broader range of problems, such as off-the-shelf property optimization, explicit negative design and partial molecular design with inpainting. We formulate SBDD as a three-dimensional conditional generation problem and present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel ligands conditioned on protein pockets. Furthermore, we show how additional constraints can be used to improve the generated drug candidates according to a variety of computational metrics.
structure-based design equivariant diffusion models
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

roipad.com › trend story
0%

Disentangled autoencoding equivariant diffusion model for controlled generation of 3D molecules

Controlled generation of 3D molecules with desired properties can speed up drug discovery. Here, the authors propose a semantics-guided diffusion model to achieve precise and data-efficient multi-p...
roipad.com › narrative analysis
0%

Diffusion-models

Diffusion models are advancing significantly in drug discovery, specifically for the "controlled generation of 3D molecules" with desired properties. This technical trend leverages deep learning to...
crossref.org › academic paper
0%

Accurate structure prediction of biomolecular interactions with AlphaFold 3

AbstractThe introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and desig...
crossref.org › academic paper
0%

Generalized biomolecular modeling and design with RoseTTAFold All-Atom

Deep-learning methods have revolutionized protein structure prediction and design but are presently limited to protein-only systems. We describe RoseTTAFold All-Atom (RFAA), which combines a residu...
crossref.org › academic paper
0%

A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation

Abstract Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in widespread use. Generat...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Structure-based drug design with equivariant diffusion models'?

This literature focuses on: AbstractStructure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods leverage structural data of drugs with their protein targets t...

Are there open-source GitHub repositories related to Structure-based drug design with equivariant diffusion models?

Yes, open-source projects like slowmist/openclaw-security-practice-guide (This guide is designed for OpenClaw itself (Agent-facing), not as a traditional human-only hardening checklist.) are actively building upon these concepts.

Which startups are commercializing the technology behind Structure-based drug design with equivariant diffusion models?

Products like ShowcasePro are bringing this to market. Their focus is: Convert photos into elegant designs for marketing + sharing.

Are there commercial applications of 'Structure-based drug design with equivariant diffusion models' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Disentangled autoencoding equivariant diffusion model for controlled generation of 3D molecules' discusses this: Controlled generation of 3D molecules with desired properties can speed up drug discovery. Here, the authors propose a semantics-guided diffusion m...

What other academic literature is closely related to 'Structure-based drug design with equivariant diffusion models'?

Yes, highly correlated activity was mapped. An entry titled 'Accurate structure prediction of biomolecular interactions with AlphaFold 3' discusses this: AbstractThe introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge ra...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative